HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)
South Korea · Delayed Price · Currency is KRW 5,000.00
-200.00 (-3.85%)
At close: Oct 2, 2026
HYUNDAI BIOLAND Market Cap
HYUNDAI BIOLAND has a market cap or net worth of 150 billion as of October 2, 2026. Its market cap has increased by 4.38% in one year.
Market Cap
150.00B
Enterprise Value
130.54B
Revenue
140.70B
Ranking
n/a
PE Ratio
11.23
Stock Price
5,000.00
ChartMarket Cap Chart
Since March 1, 2002, HYUNDAI BIOLAND's market cap has increased from 25.40B to 150.00B, an increase of 490.48%. That is a compound annual growth rate of 7.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 150.00B | 16.41% |
| Dec 30, 2025 | 128.85B | -4.87% |
| Dec 30, 2024 | 135.45B | -9.52% |
| Dec 28, 2023 | 149.70B | -25.80% |
| Dec 29, 2022 | 201.75B | -21.80% |
| Dec 30, 2021 | 258.00B | -29.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DAE HWA Pharmaceutical | 213.70B |
| GC WellBeing | 200.75B |
| CellBion | 184.67B |
| Vivozon Pharmaceutical | 177.79B |
| NOVAREX | 175.98B |
| Kyung Dong Pharmaceutical | 146.79B |
| Cosmax Nbt | 138.33B |
| PHARMARESEARCH BIO | 123.12B |